Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.40 |
| ▸ | ADH1C | P00326 | 1/20 | 0.40 |
| ▸ | ADH1A | P07327 | 1/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
| ▸ | ADH7 | P40394 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10480702 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4271949 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4275345 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4276528 | 0.97 | OPRM1 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL31274600 | 0.95 | ACE2 (0.50) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4275206 | 0.95 | ACE2 (0.52) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4281824 | 0.95 | ACE2 (0.52) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4276688 | 0.95 | ACE2 (0.52) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4275317 | 0.95 | ACE2 (0.52) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL4275509 | 0.95 | ACE2 (0.52) | ACE2OPRM1SPHK1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | claimed |
| CN-120036318-A | Curved line purple gray butterfly attractant composition and application thereof | 广西大学 | 2025-05-27 | — | — | CN | claimed |
| WO-2025090929-A1 | APPARATUS, SYSTEMS, AND METHODS FOR DETECTING HYPOGLYCEMIA | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2025-05-01 | — | — | WO | claimed |
| CN-114019046-B | Technical method for judging edible quality of rice based on volatile components of rice | 浙江农林大学 | 2024-11-15 | — | — | CN | claimed |
| US-20240230571-A1 | VOLATILE COMPOUND SOURCE LOCATING SYSTEMS | US DEPARTMENT OF ENERGY | 2024-07-11 | — | — | US | claimed |
| US-11850035-B2 | Breath analysis methodology for medical diagnostics | UNIVERSITY OF MIAMI (US) | 2023-12-26 | — | — | US | claimed |
| CN-114019046-A | Technical method for judging eating quality of paddy based on volatile components of paddy | 浙江农林大学 | 2022-02-08 | — | — | CN | claimed |
| US-20210228104-A1 | BREATH ANALYSIS METHODOLOGY FOR MEDICAL DIAGNOSTICS | UNIVERSITY OF MIAMI | 2021-07-29 | — | — | US | claimed |
| EP-3846691-A2 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | Kozhnosys Private Limited (IN) | 2021-07-14 | — | — | EP | claimed |
| US-20210186367-A1 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | KOZHNOSYS PRIVATE LIMITED (IN) | 2021-06-24 | — | — | US | claimed |
| US-20130143247-A1 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2013-06-06 | — | — | US | claimed |
| WO-2012023138-A2 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2012-02-23 | — | — | WO | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| EP-4747303-A2 | DISTILLATION OF PLASTIC WASTE TO FORM WATERPROOFING PRODUCTS | Fairway Cost Consultancy Limited (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | disclosed |
| CN-120036318-A | Curved line purple gray butterfly attractant composition and application thereof | 广西大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20070264366-A1 | Moringa crude extracts and their derived fractions with antifungal activities | ACADEMIA SINICA (TW) | 2007-11-15 | — | — | US | disclosed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | disclosed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | BCL2, BAX, EPCAM | ACE2 4419/4885OPRM1 642/4885SPHK1 854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.